Login Register Cart 0
Generic placeholder image

Current Drug Metabolism

Editor-in-Chief

ISSN (Print): 1389-2002
ISSN (Online): 1875-5453

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Curcumin Nanogel Preparations: A Promising Alternative for Psoriasis Treatment

Author(s): Asad Ahmad, Juber Akhtar*, Mohammad Ahmad, Anas Islam, Badruddeen, Mohammad Irfan Khan, Shaiber Siddiqui and Akash Srivastava

Volume 25, Issue 3, 2024

Published on: 16 May, 2024

Page: [179 - 187] Pages: 9

DOI: 10.2174/0113892002312605240508042634

Price: $65

Abstract

Curcumin is a naturally occurring polyphenolic compound extracted from the rhizomes of Curcuma longa, commonly known as turmeric. It has been used for centuries in traditional medicine and is gaining increasing attention in modern medicine owing to its potential therapeutic benefits. Psoriasis is a chronic inflammatory disease characterized by red scaly patches on the skin. Curcumin has been found to be effective in treating psoriasis by inhibiting the activity of various enzymes and proteins involved in the inflammation and proliferation of psoriatic skin cells. Nanogel preparation of curcumin has been found to be a promising approach for the delivery of compounds to treat psoriasis. Nanogels are composed of biocompatible and biodegradable crosslinked hydrogels. The nanogel formulation of curcumin increases its solubility, stability, and bioavailability, indicating that a lower dose is needed to achieve the same therapeutic effect. This review article suggests that the nanogel preparation of curcumin can be a better alternative for psoriasis treatment as it increases the bioavailability and stability of curcumin and also reduces the required dosage. This study suggests that curcumin nanogel preparations are promising alternatives to traditional psoriasis treatments and could potentially be used as a more effective and safe treatment option. This article highlights the need for further research to fully understand the potential of curcumin nanogel preparations for psoriasis treatment in humans.

Next »
[1]
Christophers, E. Psoriasis − epidemiology and clinical spectrum. Clin. Exp. Dermatol., 2001, 26(4), 314-320.
[http://dx.doi.org/10.1046/j.1365-2230.2001.00832.x] [PMID: 11422182]
[2]
Parisi, R.; Symmons, D.P.M.; Griffiths, C.E.M.; Ashcroft, D.M. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J. Invest. Dermatol., 2013, 133(2), 377-385.
[http://dx.doi.org/10.1038/jid.2012.339] [PMID: 23014338]
[3]
Gibbs, S. Skin disease and socioeconomic conditions in rural Africa: Tanzania. Int. J. Dermatol., 1996, 35(9), 633-639.
[http://dx.doi.org/10.1111/j.1365-4362.1996.tb03687.x] [PMID: 8876289]
[4]
Rachakonda, T.D.; Schupp, C.W.; Armstrong, A.W. Psoriasis prevalence among adults in the United States. J. Am. Acad. Dermatol., 2014, 70(3), 512-516.
[http://dx.doi.org/10.1016/j.jaad.2013.11.013] [PMID: 24388724]
[5]
Danielsen, K.; Olsen, A.O.; Wilsgaard, T.; Furberg, A.S. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br. J. Dermatol., 2013, 168(6), 1303-1310.
[http://dx.doi.org/10.1111/bjd.12230] [PMID: 23374051]
[6]
Ortonne, J.P.; Chimenti, S.; Luger, T.; Puig, L.; Reid, F.; Trüeb, R.M. Scalp psoriasis: European consensus on grading and treatment algorithm. J. Eur. Acad. Dermatol. Venereol., 2009, 23(12), 1435-1444.
[http://dx.doi.org/10.1111/j.1468-3083.2009.03372.x] [PMID: 19614856]
[7]
Nestle, F.O.; Kaplan, D.H.; Barker, J. Psoriasis. N. Engl. J. Med., 2009, 361(5), 496-509.
[http://dx.doi.org/10.1056/NEJMra0804595] [PMID: 19641206]
[8]
Ko, H.C.; Jwa, S.W.; Song, M.; Kim, M.B.; Kwon, K.S. Clinical course of guttate psoriasis: Long-term follow-up study. J. Dermatol., 2010, 37(10), 894-899.
[http://dx.doi.org/10.1111/j.1346-8138.2010.00871.x] [PMID: 20860740]
[9]
Martin, B.A.; Chalmers, R.J.; Telfer, N.R. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch. Dermatol., 1996, 132(6), 717-718.
[http://dx.doi.org/10.1001/archderm.1996.03890300147032] [PMID: 8651734]
[10]
Navarini, A.A.; Burden, A.D.; Capon, F.; Mrowietz, U.; Puig, L.; Köks, S.; Kingo, K.; Smith, C.; Barker, J.N.; Network, E. European consensus statement on phenotypes of pustular psoriasis. J. Eur. Acad. Dermatol. Venereol., 2017, 31(11), 1792-1799.
[http://dx.doi.org/10.1111/jdv.14386] [PMID: 28585342]
[11]
Sommer, D.M.; Jenisch, S.; Suchan, M.; Christophers, E.; Weichenthal, M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch. Dermatol. Res., 2006, 298(7), 321-328.
[http://dx.doi.org/10.1007/s00403-006-0703-z] [PMID: 17021763]
[12]
Gerdes, S.; Mrowietz, U.; Boehncke, W.H. Komorbidität bei Psoriasis vulgaris. Hautarzt, 2016, 67(6), 438-444.
[http://dx.doi.org/10.1007/s00105-016-3805-3] [PMID: 27221798]
[13]
Gelfand, J.M.; Dommasch, E.D.; Shin, D.B.; Azfar, R.S.; Kurd, S.K.; Wang, X.; Troxel, A.B. The risk of stroke in patients with psoriasis. J. Invest. Dermatol., 2009, 129(10), 2411-2418.
[http://dx.doi.org/10.1038/jid.2009.112] [PMID: 19458634]
[14]
Prodanovich, S.; Kirsner, R.S.; Kravetz, J.D.; Ma, F.; Martinez, L.; Federman, D.G. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch. Dermatol., 2009, 145(6), 700-703.
[http://dx.doi.org/10.1001/archdermatol.2009.94] [PMID: 19528427]
[15]
Gelfand, J.M.; Neimann, A.L.; Shin, D.B.; Wang, X.; Margolis, D.J.; Troxel, A.B. Risk of myocardial infarction in patients with psoriasis. JAMA, 2006, 296(14), 1735-1741.
[http://dx.doi.org/10.1001/jama.296.14.1735] [PMID: 17032986]
[16]
Ahlehoff, O.; Gislason, G.H.; Charlot, M.; Jørgensen, C.H.; Lindhardsen, J.; Olesen, J.B.; Abildstrøm, S.Z.; Skov, L.; Torp-Pedersen, C.; Hansen, P.R. Psoriasis is associated with clinically significant cardiovascular risk: A Danish nationwide cohort study. J. Intern. Med., 2011, 270(2), 147-157.
[http://dx.doi.org/10.1111/j.1365-2796.2010.02310.x] [PMID: 21114692]
[17]
Kimball, A.B.; Guerin, A.; Latremouille-Viau, D.; Yu, A.P.; Gupta, S.; Bao, Y.; Mulani, P. Coronary heart disease and stroke risk in patients with psoriasis: Retrospective analysis. Am. J. Med., 2010, 123(4), 350-357.
[http://dx.doi.org/10.1016/j.amjmed.2009.08.022] [PMID: 20362755]
[18]
Rapp, S.R.; Feldman, S.R.; Exum, M.L.; Fleischer, A.B., Jr; Reboussin, D.M. Psoriasis causes as much disability as other major medical diseases. J. Am. Acad. Dermatol., 1999, 41(3), 401-407.
[http://dx.doi.org/10.1016/S0190-9622(99)70112-X] [PMID: 10459113]
[19]
Szepietowski, J.C.; Reich, A. Pruritus in psoriasis: An update. Eur. J. Pain, 2016, 20(1), 41-46.
[http://dx.doi.org/10.1002/ejp.768] [PMID: 26415584]
[20]
Fleming, P.; Bai, J.W.; Pratt, M.; Sibbald, C.; Lynde, C.; Gulliver, W.P. The prevalence of anxiety in patients with psoriasis: A systematic review of observational studies and clinical trials. J. Eur. Acad. Dermatol. Venereol., 2017, 31(5), 798-807.
[http://dx.doi.org/10.1111/jdv.13891] [PMID: 27620704]
[21]
Sampogna, F.; Tabolli, S.; Abeni, D. Living with psoriasis: Prevalence of shame, anger, worry, and problems in daily activities and social life. Acta Derm. Venereol., 2012, 92(3), 299-303.
[http://dx.doi.org/10.2340/00015555-1273] [PMID: 22678565]
[22]
Li, X.M.; Wu, Z.Z.; Zhang, B.; Pan, Y.; Meng, R.; Chen, H.Q. Fabrication of chitosan hydrochloride and carboxymethyl starch complex nanogels as potential delivery vehicles for curcumin. Food Chem., 2019, 293, 197-203.
[http://dx.doi.org/10.1016/j.foodchem.2019.04.096] [PMID: 31151601]
[23]
Mangalathillam, S.; Rejinold, N.S.; Nair, A.; Lakshmanan, V.K.; Nair, S.V.; Jayakumar, R. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale, 2012, 4(1), 239-250.
[http://dx.doi.org/10.1039/C1NR11271F] [PMID: 22080352]
[24]
Rafiee, Z.; Nejatian, M.; Daeihamed, M.; Jafari, S.M. Application of curcumin-loaded nanocarriers for food, drug and cosmetic purposes. Trends Food Sci. Technol., 2019, 88, 445-458.
[http://dx.doi.org/10.1016/j.tifs.2019.04.017]
[25]
Araiza-Calahorra, A.; Akhtar, M.; Sarkar, A. Recent advances in emulsion-based delivery approaches for curcumin: From encapsulation to bioaccessibility. Trends Food Sci. Technol., 2018, 71, 155-169.
[http://dx.doi.org/10.1016/j.tifs.2017.11.009]
[26]
Wakte, P.S.; Sachin, B.S.; Patil, A.A.; Mohato, D.M.; Band, T.H.; Shinde, D.B. Optimization of microwave, ultra-sonic and supercritical carbon dioxide assisted extraction techniques for curcumin from Curcuma longa. Separ. Purif. Tech., 2011, 79(1), 50-55.
[http://dx.doi.org/10.1016/j.seppur.2011.03.010]
[27]
Ammon, H.; Wahl, M. Pharmacology of Curcuma longa. Planta Med., 1991, 57(1), 1-7.
[http://dx.doi.org/10.1055/s-2006-960004] [PMID: 2062949]
[28]
Tapal, A.; Tiku, P.K. Complexation of curcumin with soy protein isolate and its implications on solubility and stability of curcumin. Food Chem., 2012, 130(4), 960-965.
[http://dx.doi.org/10.1016/j.foodchem.2011.08.025]
[29]
Payton, F.; Sandusky, P.; Alworth, W.L. NMR study of the solution structure of curcumin. J. Nat. Prod., 2007, 70(2), 143-146.
[http://dx.doi.org/10.1021/np060263s] [PMID: 17315954]
[30]
Zhang, J.; Zhang, Y.; Wang, H.; Chen, W.; Lu, A.; Li, H.; Kang, L.; Wu, C. Solubilisation and Enhanced Oral Absorption of Curcumin Using a Natural Non-Nutritive Sweetener Mogroside V. Int. J. Nanomedicine, 2023, 18, 1031-1045.
[http://dx.doi.org/10.2147/IJN.S395266] [PMID: 36855540]
[31]
Moballegh Nasery, M.; Abadi, B.; Poormoghadam, D.; Zarrabi, A.; Keyhanvar, P.; Khanbabaei, H.; Ashrafizadeh, M.; Mohammadinejad, R.; Tavakol, S.; Sethi, G. Curcumin delivery mediated by bio-based nanoparticles: A review. Molecules, 2020, 25(3), 689.
[http://dx.doi.org/10.3390/molecules25030689] [PMID: 32041140]
[32]
Yu, W.; Liu, X.; Cai, D.; Zheng, J.; Lao, B.; Huang, M.; Zhong, G. Regional distributions of curcumin and tetrahydrocurcumin in the liver and small intestine of rats when orally co-administered with quercetin and paeoniflorin. Biopharm. Drug Dispos., 2023, 44(2), 183-191.
[http://dx.doi.org/10.1002/bdd.2346] [PMID: 36638836]
[33]
Sanlier, N.; Kocabas, Ş.; Erdogan, K.; Sanlier, N.T. Effects of curcumin, its analogues, and metabolites on various cancers: Focusing on potential mechanisms. Food Rev. Int., 2023, 39(8), 5356-5376.
[http://dx.doi.org/10.1080/87559129.2022.2067173]
[34]
Obeid, M.A.; Alsaadi, M.; Aljabali, A.A. Recent updates in curcumin delivery. J. Liposome Res., 2023, 33(1), 53-64.
[http://dx.doi.org/10.1080/08982104.2022.2086567] [PMID: 35699160]
[35]
Tahara, Y.; Akiyoshi, K. Current advances in self-assembled nanogel delivery systems for immunotherapy. Adv. Drug Deliv. Rev., 2015, 95, 65-76.
[http://dx.doi.org/10.1016/j.addr.2015.10.004] [PMID: 26482187]
[36]
Ahmed, S.; Alhareth, K.; Mignet, N. Advancement in nanogel formulations provides controlled drug release. Int. J. Pharm., 2020, 584, 119435.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119435] [PMID: 32439585]
[37]
Taha, M.; Alhakamy, N.A.; Md, S.; Ahmad, M.Z.; Rizwanullah, M.; Fatima, S.; Ahmed, N.; Alyazedi, F.M.; Karim, S.; Ahmad, J. Nanogels as Potential Delivery Vehicles in Improving the Therapeutic Efficacy of Phytopharmaceuticals. Polymers (Basel), 2022, 14(19), 4141.
[http://dx.doi.org/10.3390/polym14194141] [PMID: 36236089]
[38]
D’Angelo, N.A.; Noronha, M.A.; Kurnik, I.S.; Câmara, M.C.C.; Vieira, J.M.; Abrunhosa, L.; Martins, J.T.; Alves, T.F.R.; Tundisi, L.L.; Ataide, J.A.; Costa, J.S.R.; Jozala, A.F.; Nascimento, L.O.; Mazzola, P.G.; Chaud, M.V.; Vicente, A.A.; Lopes, A.M. Curcumin encapsulation in nanostructures for cancer therapy: A 10-year overview. Int. J. Pharm., 2021, 604, 120534.
[http://dx.doi.org/10.1016/j.ijpharm.2021.120534] [PMID: 33781887]
[39]
Patel, S.S.; Acharya, A.; Ray, R.S.; Agrawal, R.; Raghuwanshi, R.; Jain, P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Crit. Rev. Food Sci. Nutr., 2020, 60(6), 887-939.
[http://dx.doi.org/10.1080/10408398.2018.1552244] [PMID: 30632782]
[40]
Khezri, K.; Saeedi, M.; Mohammadamini, H.; Zakaryaei, A.S. A comprehensive review of the therapeutic potential of curcumin nanoformulations. Phytother. Res., 2021, 35(10), 5527-5563.
[http://dx.doi.org/10.1002/ptr.7190] [PMID: 34131980]
[41]
Kunnumakkara, A.B.; Bordoloi, D.; Padmavathi, G.; Monisha, J.; Roy, N.K.; Prasad, S.; Aggarwal, B.B. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. Br. J. Pharmacol., 2017, 174(11), 1325-1348.
[http://dx.doi.org/10.1111/bph.13621] [PMID: 27638428]
[42]
Kesharwani, P.; Jain, A.; Srivastava, A.K.; Keshari, M.K. Systematic development and characterization of curcumin-loaded nanogel for topical application. Drug Dev. Ind. Pharm., 2020, 46(9), 1443-1457.
[http://dx.doi.org/10.1080/03639045.2020.1793998] [PMID: 32644836]
[43]
Deng, Y.; Chang, C.; Lu, Q. The inflammatory response in psoriasis: A comprehensive review. Clin. Rev. Allergy Immunol., 2016, 50(3), 377-389.
[http://dx.doi.org/10.1007/s12016-016-8535-x] [PMID: 27025861]
[44]
Aggarwal, B.B.; Harikumar, K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int. J. Biochem. Cell Biol., 2009, 41(1), 40-59.
[http://dx.doi.org/10.1016/j.biocel.2008.06.010] [PMID: 18662800]
[45]
Kang, D.; Li, B.; Luo, L.; Jiang, W.; Lu, Q.; Rong, M.; Lai, R. Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie, 2016, 123, 73-80.
[http://dx.doi.org/10.1016/j.biochi.2016.01.013] [PMID: 26826458]
[46]
Rahimi, K.; Ahmadi, A.; Hassanzadeh, K.; Soleimani, Z.; Sathyapalan, T.; Mohammadi, A.; Sahebkar, A. Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states. Autoimmun. Rev., 2019, 18(7), 738-748.
[http://dx.doi.org/10.1016/j.autrev.2019.05.012] [PMID: 31059845]
[47]
Singh, P.; Singh, S.; Garg, G.; Singh, A.K.; Rizvi, S.I. Curcumin has protective effects on ROS production and redox imbalance in an experimental oxidative-stressed model of rat. J. Biol. Active Prod. Nat., 2020, 10(6), 484-494.
[http://dx.doi.org/10.1080/22311866.2020.1864473]
[48]
Wang, Y.; Fu, S.; Lu, Y.; Lai, R.; Liu, Z.; Luo, W.; Xu, Y. Chitosan/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: A combined chemo-photodynamic therapy for psoriasis. Carbohydr. Polym., 2022, 277, 118819.
[http://dx.doi.org/10.1016/j.carbpol.2021.118819] [PMID: 34893236]
[49]
Kumari, M.; Sharma, N.; Manchanda, R.; Gupta, N.; Syed, A.; Bahkali, A.H.; Nimesh, S. PGMD/curcumin nanoparticles for the treatment of breast cancer. Sci. Rep., 2021, 11(1), 3824.
[http://dx.doi.org/10.1038/s41598-021-81701-x] [PMID: 33589661]
[50]
Seok, HY; Rejinold, NS; Lekshmi, KM; Cherukula, K; Park, IK; Kim, YC CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: in vitro and in vivo evaluation. J.Control. Rel., 2018, 280, 20-30.
[51]
Tiwari, N.; Nawale, L.; Sarkar, D.; Badiger, M. Carboxymethyl cellulose-grafted mesoporous silica hybrid nanogels for enhanced cellular uptake and release of curcumin. Gels, 2017, 3(1), 8.
[http://dx.doi.org/10.3390/gels3010008] [PMID: 30920505]
[52]
Sarika, P.R.; Nirmala, R.J. Curcumin loaded gum arabic aldehyde-gelatin nanogels for breast cancer therapy. Mater. Sci. Eng. C, 2016, 65, 331-337.
[http://dx.doi.org/10.1016/j.msec.2016.04.044] [PMID: 27157759]
[53]
Charoenkanburkang, P.; Kaewruethai, T.; Rojsitthisak, P.; Luckanagul, J. The study of physical properties and formulation of self-assembling nanogel from grafted hydrophilic polymer backbone as stabilization system for curcumin. Thaiphesatchasan, 2021, 45(1) [TJPS].
[54]
Howaili, F.; Özliseli, E.; Küçüktürkmen, B.; Razavi, S.M.; Sadeghizadeh, M.; Rosenholm, J.M. Stimuli-responsive, plasmonic nanogel for dual delivery of curcumin and photothermal therapy for cancer treatment. Front Chem., 2021, 8, 602941.
[http://dx.doi.org/10.3389/fchem.2020.602941] [PMID: 33585400]
[55]
Amanlou, N.; Parsa, M.; Rostamizadeh, K.; Sadighian, S.; Moghaddam, F. Enhanced cytotoxic activity of curcumin on cancer cell lines by incorporating into gold/chitosan nanogels. Mater. Chem. Phys., 2019, 226, 151-157.
[http://dx.doi.org/10.1016/j.matchemphys.2018.12.089]
[56]
Tran, D.H.N.; Nguyen, T.H.; Vo, T.N.N.; Pham, L.P.T.; Vo, D.M.H.; Nguyen, C.K.; Bach, L.G.; Nguyen, D.H. Self-assembled poly(ethylene glycol) methyl ether-grafted gelatin nanogels for efficient delivery of curcumin in cancer treatment. J. Appl. Polym. Sci., 2019, 136(20), 47544.
[http://dx.doi.org/10.1002/app.47544]
[57]
Mahajan, HS; Patil, PP. In situ cross linked chitosan-gellan gum polyelectrolyte complex based nanogels containing curcumin for delivery to cancer Cells. Indian journal of pharmaceutical education and research., 2017, 51(S2), 40-45.
[http://dx.doi.org/10.5530/ijper.51.2s.48]
[58]
Luckanagul, J.A.; Pitakchatwong, C.; Ratnatilaka Na Bhuket, P.; Muangnoi, C.; Rojsitthisak, P.; Chirachanchai, S.; Wang, Q.; Rojsitthisak, P. Chitosan-based polymer hybrids for thermo-responsive nanogel delivery of curcumin. Carbohydr. Polym., 2018, 181, 1119-1127.
[http://dx.doi.org/10.1016/j.carbpol.2017.11.027] [PMID: 29253940]
[59]
Sarika, P.R. Nirmala Rachel James, and Deepa K. Raj. “Preparation, characterization and biological evaluation of curcumin loaded alginate aldehyde–gelatin nanogels.”. Mater. Sci. Eng. C, 2016, 68, 251-257.
[http://dx.doi.org/10.1016/j.msec.2016.05.046]
[60]
Feng, J.; Wu, S.; Wang, H.; Liu, S. Improved bioavailability of curcumin in ovalbumin-dextran nanogels prepared by Maillard reaction. J. Funct. Foods, 2016, 27, 55-68.
[http://dx.doi.org/10.1016/j.jff.2016.09.002]
[61]
Manzanares-Guevara, L.A.; Licea-Claverie, A.; Oroz-Parra, I.; Bernaldez-Sarabia, J.; Diaz-Castillo, F.; Licea-Navarro, A.F. Smart Nanoformulation Based on Stimuli-Responsive Nanogels and Curcumin: Promising Therapy against Colon Cancer. ACS Omega, 2020, 5(16), 9171-9184.
[http://dx.doi.org/10.1021/acsomega.9b04390] [PMID: 32363269]
[62]
González-Ortega, L.A.; Acosta-Osorio, A.A.; Grube-Pagola, P.; Palmeros-Exsome, C.; Cano-Sarmiento, C.; García-Varela, R.; García, H.S. Anti-inflammatory activity of curcumin in gel carriers on mice with atrial edema. J. Oleo Sci., 2020, 69(2), 123-131.
[http://dx.doi.org/10.5650/jos.ess19212] [PMID: 32023579]
[63]
Pathan, I.B.; Munde, S.J.; Shelke, S.; Ambekar, W.; Mallikarjuna Setty, C. Curcumin loaded fish scale collagen-HPMC nanogel for wound healing application: Ex-vivo and In-vivo evaluation. Int. J. Polym. Mater., 2019, 68(4), 165-174.
[http://dx.doi.org/10.1080/00914037.2018.1429437]
[64]
Gera, M.; Sharma, N.; Ghosh, M.; Huynh, D.L.; Lee, S.J.; Min, T.; Kwon, T.; Jeong, D.K. Nanoformulations of curcumin: An emerging paradigm for improved remedial application. Oncotarget, 2017, 8(39), 66680-66698.
[http://dx.doi.org/10.18632/oncotarget.19164] [PMID: 29029547]
[65]
Yallapu, M.M.; Nagesh, P.K.B.; Jaggi, M.; Chauhan, S.C. Therapeutic applications of curcumin nanoformulations. AAPS J., 2015, 17(6), 1341-1356.
[http://dx.doi.org/10.1208/s12248-015-9811-z] [PMID: 26335307]
[66]
Karthikeyan, A.; Senthil, N.; Min, T. Nanocurcumin: A promising candidate for therapeutic applications. Front. Pharmacol., 2020, 11, 487.
[http://dx.doi.org/10.3389/fphar.2020.00487] [PMID: 32425772]
[67]
Padalkar, R.; Madgulkar, A.; Mate, R.; Pawar, A.; Shinde, A.; Lohakare, S. Investigation of curcumin nanoparticles and D –panthenol for diabetic wound healing in wistar rats: Formulation, statistical optimization and in vivo evaluation. J. Drug Deliv. Sci. Technol., 2024, 93, 105390.
[http://dx.doi.org/10.1016/j.jddst.2024.105390]
[68]
Tomar, Y.; Maheshwari, S.; Gorantla, S.; Singhvi, G. Curcumin loaded liquid crystalline nanoparticles for enhanced topical application: Design, characterization, ex vivo and dermatokinetic evaluation. J. Drug Deliv. Sci. Technol., 2024, 92, 105391.
[http://dx.doi.org/10.1016/j.jddst.2024.105391]
[69]
Gupta, Y.; Kumar, N.; Shukla, A.; Rai, V. Treatment of psoriasis with the help of curcumin hydrogel. J. Res. Appl. Sci. Biotechno., 2023, 2(2), 224-230.
[http://dx.doi.org/10.55544/jrasb.2.2.32]
[70]
Murphy, E.C.; Schaffter, S.W.; Friedman, A.J. Nanotechnology for psoriasis therapy. Curr. Dermatol. Rep., 2019, 8(1), 14-25.
[http://dx.doi.org/10.1007/s13671-019-0248-y]
[71]
Katari, O.; Jain, S. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics for the treatment of psoriasis. Expert Opin. Drug Deliv., 2021, 18(12), 1857-1872.
[http://dx.doi.org/10.1080/17425247.2021.2011857] [PMID: 34823429]
[72]
Quispe, C.; Cruz-Martins, N.; Manca, M.L.; Manconi, M.; Sytar, O.; Hudz, N.; Shanaida, M.; Kumar, M.; Taheri, Y.; Martorell, M.; Sharifi-Rad, J.; Pintus, G.; Cho, W.C. Nanoderived therapeutic formulations with curcumin in inflammation-related diseases. Oxid. Med. Cell. Longev., 2021, 2021, 1-15.
[http://dx.doi.org/10.1155/2021/3149223] [PMID: 34584616]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy